To read the full article below, please use the navigation arrows at the bottom of each page which become visible when you place your cursor at the bottom of each page.
twst-Isoray-15-jun-21
Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific Session
The result from first patient dosed with VMT-α-NET in India on a compassionate use basis showed favorable responses. The initial response was...
